Merck to stop Phase 3 KEYLYNK-010 trial investigating Combo therapy of KEYTRUDA and LYNPARZA MD Bureau18 March 2022 2:00 PM ISTMerck, known as MSD outside the United States and Canada, today announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA,...
WHO recommends Molnupiravir for high risk patients MD Bureau4 March 2022 12:09 PM ISTThe expert panel conditionally recommended the pill, molnupiravir, for patients with the non-severe disease who are at high risk of hospitalization.
Merck expects 2022 sales up nearly 20 percent, mostly on molnupiravir Ruchika Sharma6 Feb 2022 9:00 AM ISTNew Delhi: Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new...
Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Fate of Pfizer COVID pill Paxlovid to be decided by EU regulator by January end: Report Ruchika Sharma26 Jan 2022 9:30 AM ISTBrussels: The European Union's drug regulator is set to decide whether to approve Pfizer's Covid-19 pill at the end of this month, before a final...
No USFDA approval for Merck cough drug Gefapixant Ruchika Sharma25 Jan 2022 12:47 PM ISTNew Delhi: Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 9:00 AM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
Merck to supply 3 million doses of molupiravir to UNICEF Dr. Divya Colin20 Jan 2022 6:02 PM IST Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement...
Merck COVID pill Molnupiravir likely to get WHO recommendation in February Ruchika Sharma15 Jan 2022 1:00 PM ISTNew Delhi: The World Health Organization (WHO) is currently reviewing Merck's COVID-19 antiviral oral pill molnupiravir and a recommendation will...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 3:53 PM IST"Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high...
Pfizer to supply more 10 million courses of COVID pills to US Medical Dialogues Bureau5 Jan 2022 9:00 AM IST"These pills will be delivered in the coming months and have been shown to dramatically decrease hospitalization and death from COVID19," the White...
Can DCGI approved Molnupiravir bolster India's fight against COVID? Farhat Nasim3 Jan 2022 11:45 PM ISTNew Delhi: As countries prepare themselves to fight a possible 'next wave'. The new variant – Omicron has been making headline and a surge in Covid-19...
